# 更新日志0.9
新增S蛋白的氨基酸变异和对应核苷酸变异已经整理底表，原始株核苷酸懒癌犯了查论文时再补。因为要确认变异位点的论文内容，能力有限怕错漏过多，拟每5条更新一次，主思维导图尽量简洁。
因为纯外行，查找论文时时间顺序比较随机，有新内容随时补充。
## 一、Spike_K417N：热门组合突变，与S:E484K、S:N501Y组合形成免疫逃逸和ACE2结合双增益。单独的K417N突变作用是减少抗体中和，减少ACE2结合。
<html>
<body>
<!--StartFragment-->

氨基酸突变| 突变数量| 核苷酸突变 | 突变数量| 备注
--|--|--|--|--
S:K417N|7,619,525|G22813T|7,656,961|--
S:K417T|161,288|A22812C|161,225|--

相关论文：
> **1、 病毒群体基因组学揭示宿主和感染性对 SARS-CoV-2 适应环境的影响 https://doi.org/10.1101/2021.12.30.474516**
>
>我们还发现417位点（K417N/beta；K417T/gamma）和501位点的突变在95%的分离株中存在物理连锁（124,260/131,459）。由于417位点的突变以ACE2结合为代价减少了抗体中和，而N501Y增加了ACE2亲和力，因此数据表明，一些突变可以组合起来减轻单个突变的有害影响。 
>
>We also found that mutations at site 417 (K417N/beta; K417T/gamma) and 501 were physically linked in 95% of isolates (124,260/131,459). Because mutations at site 417 reduced antibody neutralization at a cost of ACE2 binding, and N501Y increased ACE2 affinity, the data suggested that some mutations can combine to alleviate the detrimental effect of individual variants.
>
>RBD(K417N/T)位置417处的HFV提出了一个特别有趣的案例。虽然这些突变减少了治疗性和恢复性抗体的中和作用，这是以降低ACE2结合亲和力为代价而发生的。我们发现，如果不添加补偿性突变N501Y，该位点的突变就无法成功传播。实验研究证实，虽然单独使用K417N会导致ACE2结合亲和力显着下降，但其与N501Y的结合导致结合力比野生型强3倍（尽管与单独使用N501Y相比仍低2倍）。最近，K417N也在delta的两个亚系（AY.1、AY.2）中被发现。虽然这些变体不包括N501Y，但它们确实包括增加ACE2结合亲和力的不同补偿突变L452R。 
>
>The HFV at position 417 of the RBD (K417N/T) presented a particularly interesting case. While these mutations reduce neutralization of therapeutic and convalescent antibodies47,58, this occurs at the fitness cost of reduced ACE2 binding affinity. We found that mutations at this site have not been successful in spreading without the addition of the compensatory mutation N501Y. Experimental studies have confirmed that while K417N alone results in a significant drop in ACE2 binding affinity, its combination with N501Y resulted in 3-fold stronger binding than wild-type (although still 2-fold less compared to N501Y alone)74. More recently, K417N has also been found in two sub-lineages of delta (AY.1, AY.2). While these variants do not include N501Y, they do include a different compensatory mutation that increases ACE2 binding affinity, L452R.

>**2、SARS-CoV-2 B.1.351和P.1变异株受体结合区突变的功能效应 https://doi.org/10.3389/fimmu.2021.757197**
>
>结果表明，417、484和501位的三个残基取代似乎对RBD具有非常不同的功能影响。赖氨酸的取代417与天冬酰胺(K417N)或苏氨酸(K417T)的结合会导致RBD/ACE-2亲和力显着降低，而N501Y对ACE-2的亲和力增加十倍。这些替代似乎都没有对恢复期或接种疫苗的个体的抗体中和产生重大影响。相比之下，E484K显示出显着的抗体逃避能力，而不会显着影响亲和力。结合B.1.351和P.1RBD变体，两种不同的K417取代也降低了整体亲和力，但该影响部分被E484K和N501Y功能获得性变化所抵消。我们的结果表明，这三种突变的组合在与ACE-2亲和力和抗体逃避能力相关的病毒适应性方面向前两步又向后退了一步。
>
>The results show that the three residue substitutions in positions 417, 484, and 501 seem to have very different functional impacts on the RBD. The substitution of lysine417 to either an asparagine (K417N) or a threonine (K417T) results in a significant reduction in RBD/ACE-2 affinity, while the N501Y confers a ten-fold affinity increase towards ACE-2. Neither of these substitutions seems to have a major effect on the antibody neutralization from convalescent or vaccinated individuals. In contrast, the E484K displays a significant antibody evasion capacity without significantly impacting the affinity. Combined in the B.1.351 and P.1 RBD variants, the two different K417 substitutions also lower the overall affinity, but the effect is in part counterbalanced by the E484K and N501Y gain-of-function changes. Our results suggest that the combination of these three mutations is a two-step forward and one step back in terms of viral fitness related to ACE-2 affinity and antibody evasion capacity.
>
>E484K和N501Y突变增强了B.1.351和P.1针对自然诱导的抗体介导的免疫的逃避能力
我们的目的是确定这些突变是否可以增强病毒适应性，而不仅仅是与ACE-2受体结合的显着增益。为此，我们使用经过验证的抗体抑制ELISA评估了它们的免疫逃避潜力，该ELISA测量了ACE-2/RBD相互作用的血清或单克隆抗体的抑制程度(%)。的血清的抑制效力首先，我们确定了来自康复的COVID-19患者(n=150)。我们观察到，与wt相比，E484K和N501YRBD的中值抑制降低了1.9倍和1.5倍，而417位的替换却产生了令人费解的相反效果，K417N和K417T的抑制增益明显增加了1.4倍和1.2倍。分别（弗里德曼检验p<0.0001）。综合考虑时，B.1.351RBD(N_K_T)导致中值抑制效力降低2.4倍，而P.1(T_K_Y)则降低更显着​​3.2倍（p两者均<0.0001）。对wtRBD的抑制效力与突变显着相关（ρ值范围为0.763至0.945，斯皮尔曼等级p<0.0001）。
>
>The E484K and N501Y Mutations Enhance the Evasion Capacity of B.1.351 and P.1 Against Natural-Induced Antibody-Mediated Immunity
We aimed at determining whether the mutations could enhance viral fitness beyond the considerable gains in the binding to the ACE-2 receptor. To do so, we evaluated their immune evasion potential with a validated antibody inhibition ELISA that measures the degree of inhibition (%) of sera or monoclonal antibodies of the ACE-2/RBD interaction (18). First, we determined the inhibition potency of sera from recovered COVID-19 patients (n = 150) (Figure 3). We observed a 1.9- and 1.5-fold reduction in the median inhibition of the E484K and N501Y RBD compared to the wt, while the substitutions in the 417 position had puzzlingly opposite effects with apparent 1.4- and 1.2-fold inhibition gain for K417N and K417T, respectively (Friedman test p < 0.0001 for all). When considered in combination, the B.1.351 RBD (N_K_T) resulted in a 2.4-fold reduction in the median inhibition potency, and the P.1 (T_K_Y) in an even more dramatic 3.2-fold reduction (p < 0.0001 for both). The inhibition potencies towards the wt RBD and the mutations were significantly correlated (ρ values ranging from 0.763 to 0.945, Spearman rank p < 0.0001) (Supplementary Figure 1

>**3、N501 Y、E484 K/Q、K417 N/T、L452 R和T478 K突变对SARS-CoV-2刺突蛋白RBD的理化效应及其对病原体适应性和新出现的相关变异体产生的属性的影响  https://doi.org/10.1016/j.virol.2022.05.003**
>
>研究表明，K417N突变引起的理化效应是RBD-ACE2结合强度降低，这是当K417变为N417并在RBD-ACE2之间形成一对时，K417和D30（位于ACE2）之间盐桥丢失的结果。K484和E75（也位于ACE2中），增加病毒-细胞解离常数。这种效应可以最大限度地减少细胞中病毒的固定潜力，从而降低其感染性。但是，有趣的是，N501Y突变的共存（在95%的病例中观察到（Yuan等人，2021））重新建立了变体与宿主细胞有效相互作用的能力，恢复了感染的潜力。还表明，K417N突变与E484K突变结合时，会显着增加病毒-细胞融合（与野生型病毒或N501Y变体相比），因为E484K突变改善了与带负电的ACE2的静电互补性，通过改变从羧酸(E)至胺基(K)。尽管传染性仍然相似，但这种物理化学效应可能会赋予SARS-CoV-2更大的传播性。因此，尽管单独存在K417N突变会对感染临床过程产生负面影响，但该变体的属性会因其他突变的共存而重置。
由于其位置，有人建议K417N突变可能被选为逃避体液反应的机制，这证明表达该突变的变体有能力逃避中和抗体的作用。例如在南非(B.1.351)和巴西(P.1)出现的情况。
取代在该位置鉴定出第二个突变，其特征在于赖氨酸残基被苏氨酸（K417T）。它还被发现与N501Y和E484K突变有关。尽管彼此不同，但两者都赋予病毒变体相似的属性，尽管由于突变残基之间存在不同的生化特征而导致结合模式存在差异。
>
>It has been shown that the physicochemical effect caused by the K417N mutation is the binding strength reduction RBD-ACE2, as a consequence of the salt-bridge loss between K417 and D30 (located in ACE2) when K417 changes to N417 and forms a pair between K484 and E75 (also located in ACE2), increasing virus-cell dissociation constant (Jawad et al., 2021). This effect could minimize the virus fixation potential in the cell and, thus, decrease its infectivity. But, interestingly, the co-occurrence of the N501Y mutation (which is observed in 95% of cases (Yuan et al., 2021)), re-establishes the variant's capacity to efficiently interact with the host cell, restoring the potential for infection. Studies by Kim Y et al. (2021) have also shown that the K417N mutation, when in association with the E484K mutation, dramatically increases virus-cell fusion (compared to wild-type virus or the N501Y variant) as the E484K mutation improves the electrostatic complementarity with the negatively charged ACE2, through the change from a carboxylic acid (E) to an amine group (K). This physicochemical effect may confer greater transmissibility to SARS-CoV-2, although the infectivity remains similar (Kim et al., 2021). Therefore, despite the presence of the K417N mutation alone has a negative effect on the infection clinical course, the variant's attributes are reset by co-occurrence of other mutations.
Due to its location, it has been suggested that the K417N mutation may have been selected as a mechanism for evading the humoral response (Wang et al., 2021a), which justifies the ability to escape from neutralizing antibodies action by variants that express this mutation, such as those that emerged in South Africa (B.1.351) and in Brazil (P.1).
A second mutation was identified at this position, characterized by the substitution of the lysine residue with a threonine (K417T). It has also been found in association with the N501Y and E484K mutations. Despite being different from each other, both give similar attributes to the viral variants, although variations in the binding pattern are noted due to the different biochemical characteristics that exist among the mutated residues (Khan et al., 2021).


## 二、H69del/V70del：ΔH69/V70 不会导致抗体逃脱。ΔH69/V70 增加切割的 S2 和刺突蛋白感染性。B.1.1.7 需要 ΔH69/V70 来实现有效的裂解刺突掺入和感染性。B.1.1.7 刺突蛋白需要 ΔH69/V70 才能快速形成合胞体。与N501Y组合增加传播效率。弥补与亲和力增强 RBM 突变相关的感染性缺陷。
<html>
<body>
<!--StartFragment-->

氨基酸突变| 突变数量| 核苷酸突变 | 突变数量| 备注
--|--|--|--|--
H69del|6,463,795|del21767_21772|6,454,631|--
V70del|6,468,981|--|--|--

>**1、N501Y 刺突取代增强 SARS-CoV-2 感染和传播 https://doi.org/10.1038/s41586-021-04245-0**
>
>证实阿尔法变种更有效传播的流行病学发现SARS-CoV-2，并确定该表型的遗传决定因素，我们用Alpha中发现的八个单独的刺突基因突变中的每一个对仓鼠和HAE细胞进行了实验感染。在这些突变中，只有N501Y以及密码子69和70的删除导致仓鼠上呼吸道（鼻腔分泌物脱落增加）以及人类细胞中的复制具有一致的适应性优势。在大多数实验中，单独的N501Y具有与包含完整Alpha刺突或完整Alpha-FL的嵌合WT病毒相似的表型，表明N501Y是驱动传播增加的主要决定因素。最后，我们对具有交换刺突基因的嵌合SARS-CoV-2的研究表明——正如最近的另一项研究一样25-非刺突基因组区域可能在体内与先天免疫反应相互作用，以位点和时间依赖性方式对复制产生积极和消极的影响。
>
>To corroborate epidemiological findings of more efficient transmission of the Alpha variant1 of SARS-CoV-2, and to identify genetic determinants of this phenotype, we performed experimental infections of hamsters and HAE cells with each of the eight individual spike gene mutations found in Alpha. Of these mutations, only N501Y and the deletion of codons 69 and 70 resulted in consistent fitness advantages for replication in the upper airway of hamsters (with increased shedding in nasal secretions) as well as in human cells. In most experiments, N501Y alone had a phenotype similar to that of the chimeric WT virus containing the complete Alpha spike or the complete Alpha-FL, suggesting that N501Y is the major determinant driving increased transmission. Finally, our studies of chimeric SARS-CoV-2 with swapped spike genes suggest—as in another recent study25—that non-spike genomic regions may interact in vivo with innate immune responses to both positively and negatively affect replication in a site- and time-dependent manner.
>
>尽管Δ69-70也在水貂变种以及野生型SARS-CoV-2毒株中被发现，但它在主要变种中并未趋同进化。此外，在美国，尽管自2020年10月以来就存在，但频率并未大幅增加。这些发现证实了我们的结果，表明Δ69-70对传输的影响小于N501Y。然而，这种删除频繁同时出现与N501Y表明可能的上位性。此外，英国的初步流行病学估计表明，单独使用N501Y可使传播率增加约10%，而具有Δ69-70的菌株显示出传播率高出70-80%，表明删除对于Alpha传输也很重要。
考虑到八个刺突蛋白替换中只有两个对上呼吸道感染和传播具有一致的适应效果，其他六个突变的起源和作用值得考虑。其中第一个出现的是密码子69-70和145的删除，随后到2020年3月，除S982A之外的所有其他密码子都被删除。然而，从2020年9月开始，所有八种突变（尤其是N501Y）的患病率开始增加。我们的数据表明，其中只有Δ69-70和N501Y具有一致的表型，而其他一些突变在某些实验中降低了适应性。这表明这些其他突变是通过漂移机制（例如创始人效应和搭便车效应）发生的，并通过与Δ69-70和N501Y的连锁或重组来维持，重组在SARS-CoV-2复制过程中经常发生。其他可能性包括通过恢复期血浆进行选择或在慢性感染期间进行抗病毒治疗。正如我们对嵌合病毒的结果所表明的那样，基因组其他部分的突变也可能有助于阿尔法变体的适应性。
>
>Although Δ69–70 has also been found in a mink variant as well as in wild-type SARS-CoV-2 strains (Extended Data Table 1), it has not evolved convergently in major variants. Furthermore, in the USA, despite its presence since October, 2020, it has not increased substantially in frequency28. These findings corroborate our results indicating that Δ69–70 has less effect on transmission than N501Y. However, the frequent co-occurrence of this deletion29 with N501Y suggests possible epistasis. Furthermore, initial epidemiologic estimates from the UK have indicated that N501Y alone increased transmissibility by about 10%, whereas strains with Δ69–70 showed 70–80% higher transmissibility1, suggesting that the deletion is also important for Alpha transmission.
Considering that only two of the eight spike substitutions conferred consistent fitness effects on infection of the upper airway and transmission, the origins and roles of the other six mutations deserve consideration. The first of these to appear were deletions of codons 69–70 and 145, followed by all the other except for S982A by March 2020 (Supplementary Table 2). However, from September 2020, all eight mutations—and especially N501Y—began increasing in prevalence (Fig. 4a, Supplementary Table 2). Our data indicate that of these only Δ69–70 and N501Y have a consistent phenotype, and some of the other mutations reduced fitness in certain experiments. This suggests that these other mutations occurred through drift mechanisms such as founder and hitchhiking effects, and were maintained by linkage to Δ69–70 and N501Y, or by recombination, which occurs frequently during SARS-CoV-2 replication6. Other possibilities include selection by convalescent plasma or antiviral treatments during chronic infections. It is also likely that mutations in other parts of the genome contribute to the fitness of the Alpha variant, as indicated by our results from chimeric virus.

>**2、SARS-CoV-2 刺突缺失 H69/V70 的反复出现及其在 Alpha 变体 B.1.1.7 中的作用 https ://doi.org/10.1016/j.celrep.2021.109292**
>
>刺突蛋白 ΔH69/V70不会导致抗体逃脱 
>
>刺突蛋白 ΔH69/V70增加切割的S2和刺突蛋白感染性 
>
>B.1.1.7需要 ΔH69/V70来实现有效的裂解刺突掺入和感染性 
>
>B.1.1.7刺突蛋白需要 ΔH69/V70才能快速形成合胞体
>
>Spike ΔH69/V70 does not confer escape from antibodies
>
>Spike ΔH69/V70 increases cleaved S2 and spike infectivity
>
>B.1.1.7 requires ΔH69/V70 for efficient cleaved spike incorporation and infectivity
>
>B.1.1.7 spike requires ΔH69/V70 for rapid syncytium formation
>
>在这里，我们分析了全球SARS-CoV-2数据，发现ΔH69/V70独立发生，通常在显着的RBD氨基酸替换后出现，例如Y453F和N439K，已知这些氨基酸可促进中和抗体逃逸或改变ACE2结合，同时引起传染性缺陷，根据一些报告。尽管结构模型表明H69/V70处于暴露环中，在删除后会收缩，可能会改变抗原位点，但我们报告称ΔH69/V70不会显着降低对恢复期血清或单克隆抗体(mAb)的敏感性。从功能上讲，我们发现ΔH69/V70确实增加了刺突蛋白感染性，并补偿了RBD替代品N439K和Y453F造成的感染性缺陷。感染性的增加是由更高水平的刺突掺入病毒颗粒所驱动的。我们证明，删除对于501Y.V1(B.1.1.7)刺突蛋白的最佳感染性是必需的。我们发现，尽管B.1.1.7和野生型(WT)刺突假型病毒(PV)对一系列靶细胞类型具有相似的感染性，但单独的B.1.1.7刺突蛋白会诱导更快速的细胞-细胞感染。多核细胞的融合和形成。这两种氨基酸的修复不仅导致B.1.1.7刺突掺入病毒体的减少和感染性受损，而且还使细胞-细胞融合动力学降低回到WT水平。
>
>Here we analyze global SARS-CoV-2 data and find that ΔH69/V70 occurs independently, often emerging after a significant RBD amino acid replacement, such as Y453F and N439K, which are known to facilitate neutralizing antibody escape or alter ACE2 binding while incurring an infectivity defect, according to some reports (Motozono et al., 2021; Thomson et al., 2021). Although structural modeling indicates that H69/V70 is in an exposed loop that contracts after deletion, potentially altering an antigenic site, we report that the ΔH69/V70 does not confer significantly reduced susceptibility to convalescent sera or monoclonal antibodies (mAbs). Functionally, we find that ΔH69/V70 does increase spike infectivity and compensates for an infectivity defect resulting from the RBD replacements N439K and Y453F. The infectivity increase is driven by higher levels of spike incorporation into virions. We demonstrate that the deletion is required for optimal infectivity of the 501Y.V1 (B.1.1.7) spike protein. We show that, although B.1.1.7 and the wild-type (WT) spike pseudotyped virus (PV) have similar infectivity on a range of target cell types, the B.1.1.7 spike protein alone induces more rapid cell-cell fusion and formation of multinucleated cells. Repair of the two amino acids not only leads to reduced B.1.1.7 spike incorporation into virions and impaired infectivity but also reduces cell-cell fusion kinetics back to WT levels.
>
>我们发现ΔH69/V70不会显着降低刺突蛋白对一组康复个体血清中中和抗体或针对NTD的多种mAb结合的敏感性。此外，我们还表明，修复ΔH69/V70不会明显改变NTD抗体针对B.1.1.7刺突的效力。因此，缺失不太可能是一种免疫逃逸机制。相反，我们的实验结果表明，ΔH69/V70能够增加Wuuu-1D614G刺突PV以及带有额外RBD突变N439K或Y453F的PV的感染性，这解释了为什么在这些携带免疫逃逸突变的免疫逃逸突变之后经常观察到缺失。
>
>We find that ΔH69/V70 does not significantly reduce the sensitivity of spike to neutralizing antibodies in serum from a group of recovered individuals or binding of multiple mAbs directed against the NTD. In addition, we have shown that repair of ΔH69/V70 does not appreciably alter the potency of NTD antibodies against the B.1.1.7 spike. Thus, the deletion is unlikely to be an immune escape mechanism. Instead, our experimental results demonstrate that ΔH69/V70 is able increase infectivity of the Wuhan-1 D614G spike PV as well as the PV bearing the additional RBD mutations N439K or Y453F, explaining why the deletion is often observed after these immune escape mutations that carry infectivity cost (Motozono et al., 2021; Thomson et al., 2021). 
>
>B.1.1.7似乎在较早的时间点介导更多的细胞-细胞融合事件，混合后6小时，与WT相比，B.1.1.7的颜色重叠区域大2-3倍。有趣的是，这种增强作用通过重新插入H69和V70残基而被消除。我们得出的结论是，B.1.1.7尖峰比带有D614GWuhan-1尖峰的WT介导更快的融合动力学，后者依赖于ΔH69/V70。
>
>B.1.1.7 appeared to mediate more cell-cell fusion events over earlier time points, with the color overlap area being 2–3 times greater for B.1.1.7 compared with the WT 6 h after mixing. Interestingly, this enhancement was abrogated by re-insertion of the H69 and V70 residues (Figures 7B–7D). We conclude that B.1.1.7 spike mediates faster fusion kinetics than the WT bearing D614G Wuhan-1 spike that is dependent on ΔH69/V70.

>**3、SARS-CoV-2 变异、刺突突变和免疫逃逸 https://doi.org/10.1038/s41579-021-00573-0**
>
>实验表明，ΔH69–V70不会减少一组恢复期血清的中和作用；然而，它可以弥补与亲和力增强RBM突变相关的感染性缺陷，这种突变可能是由于免疫介导的选择而出现的。
>
>Experiments have shown that ΔH69–V70 does not reduce neutralization by a panel of convalescent sera; however, it may compensate for infectivity deficits associated with affinity-boosting RBM mutations that may emerge due to immune-mediated selection22. 

